HLA-A24-RESTRINGIERTES KREBSANTIGENPEPTID

European patent · EP1536009 · Deleted

Register entry

Publication number
EP1536009
Application number
EP03736167
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jun 12, 2003
Published
Jun 1, 2005
Granted
Apr 28, 2010
Deleted
Jun 30, 2010
Reason
Annual fee unpaid
IPC classes
C12N 15/12 (2006.01)
C12N 1/19 (2006.01)
C12N 1/21 (2006.01)
C12N 5/10 (2006.01)
C07K 7/06 (2006.01)
C07K 14/82 (2006.01)
C12P 21/02 (2006.01)
C07K 16/32 (2006.01)
A61K 38/17 (2006.01)
A61K 39/00 (2006.01)
A61K 39/395 (2006.01)
A61K 31/7088 (2006.01)
A61P 35/00 (2006.01)
Priority
JP 2002171518 12.06.2002
JP 2002275572 20.09.2002
PCT application
PCT/JP2003/007463 12.06.2003
PCT publication
WO2003/106682 24.12.2003
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 19, 2011

    Deleted, fee unpaid

    Published in Swissreg on 19.01.2011

  2. Apr 28, 2010

    Granted

    Published in Swissreg on 28.04.2010

Parties

Holder

International Institute of Cancer Immunology, Inc.

13-9, Enoki-cho, Suita-shi, Osaka-fu, JP

CHUGAI SEIYAKU KABUSHIKI KAISHA

5-1, Ukima 5-chome, Kita-ku, Tokyo, 115-8543, JP

Dainippon Sumitomo Pharma Co., Ltd.

6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi, Osaka-fu, JP

Inventor

SUGIYAMA, Haruo

Minoo-shi, Osaka 562-0036, JP

GOTOH, Masashi

Takatsuki-shi, Osaka 569-0081, JP

TAKASU, Hideo

Nishinomiya-shi, Hyogo 662-0084, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.